Organization · Venture Capital
TransPacific Venture Capital Partners
TransPacific Venture Capital Partners is a venture capital firm based in San Francisco and Sydney, specializing in healthcare investments across the Pacific Rim. They focus on late-stage clinical development in biopharmaceuticals, medical technologies, and digital health.
Overview
What TransPacific Venture Capital Partners does
What TransPacific Venture Capital Partners is
TransPacific Venture Capital Partners is a venture capital firm based in San Francisco and Sydney, specializing in healthcare investments across the Pacific Rim. They focus on late-stage clinical development in biopharmaceuticals, medical technologies, and digital health.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2018
- Approximate age
- About 8 years
- Structured capabilities
- Funder
- Last reviewed
- April 10, 2026
Official channels
Find TransPacific Venture Capital Partners elsewhere
Open the official website or a supported primary organization account.
Capability profile
TransPacific Venture Capital Partners as a funder
Investment thesis
Healthcare-focused VC investing across the Pacific Rim (US, Australia, China). Specializes in biopharmaceuticals, medical devices, and digital health. Emphasis on late-stage clinical development companies rather than seed/early.
Focus narrative
TransPacific VC primarily invests in the healthcare sector, emphasizing biopharmaceuticals, medical technologies, and digital health. The firm targets late-stage clinical development and novel therapeutics, particularly in major disease areas such as oncology and Alzheimer's disease. Additionally, it engages with advancements in healthcare delivery systems, especially those utilizing artificial intelligence.
Value beyond capital
TransPacific VC adds value to its portfolio companies through its extensive network of healthcare executives and practitioners. The firm leverages its team's deep industry expertise to provide strategic guidance, operational support, and access to key resources that can enhance the growth and success of its investments.
Focus and fit
- Stages
- Series A · Series B · Series C · Growth Equity
- Regions
- AsiaNorth AmericaOceania
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 12
Portfolio context
Notable portfolio companies include: AnaptysBio: Focuses on severe inflammatory disorders (NASDAQ: ANAB). Athenex: Operates in oncology with locations in New York and Hong Kong (NASDAQ: ATNX). Beigene, Ltd: Specializes in oncology (NASDAQ: BGNE). BeyondSpring: Focuses on oncology with operations in New York and China (NASDAQ: BYSI). G1 Therapeutics: Focuses on oncology (NASDAQ: GTHX). Immuron Limited: Specializes in oral immunotherapy (NASDAQ: IMRN). Mesoblast Ltd: Focuses on cellular medicines (NASDAQ: MESO). NeuroActiva, Inc: Focuses on neuroscience for Alzheimer's treatment (Privately held - Pre-IPO). Ovid Therapeutics: Focuses on rare neurological diseases (NASDAQ: OVID). Tiansheng Pharmaceutical Group: Involved in biopharmaceutical manufacturing and distribution (Shenzhen Stock Exchange: 002872). Tocagen: Focuses on brain cancer (NASDAQ: TOCA). Zai Labs, Ltd: Focuses on oncology and licensed products (NASDAQ: ZLAB).
Common questions
What to know about TransPacific Venture Capital Partners
Upseed classifies TransPacific Venture Capital Partners under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 10, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.